This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Next-Generation Dexcom G7 CGM
System Approved by Health Canada Expert Interview with
Michael C. Riddell, PhD

Suzanne Lepage, a private health plan strategist with over 20 years in the
group insurance industry, is joined by Michael C. Riddell, PhD, Professor,
School of Kinesiology and Health Science, Faculty of Health, York University
diabetes registry recently published in Diabetic Medicine.

Coverage Update

          All NIHB Plan Members Ages 2 Years and Older
          Managing their Type 1 and Type 2 Diabetes with Insulin
          are Eligible for Dexcom G6 Coverage

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Key findings from a cost-effectiveness analysis (CEA) for adults with insulin-treated
type 2 diabetes in Canada suggests the use of Dexcom G6 Real-Time Continuous Glucose
Monitoring (rtCGM) provides a cost-effective disease management option relative to
SMBG. The CEA is built on data from the growing body of evidence that shows rtCGM
to be transformative for many people living with diabetes.

Featured Article

CGM use Lowers Hospitalizations, may Reduce Mortality in Type 1 and Type 2 Diabetes

New Video Resource

ADA 2023 Highlights: The Clinical and Economic Value of CGM

Watch Now

Featured Update

2021 Update from the Diabetes Canada Clinical Practice Guidelines
Expert Working Group on Blood Glucose Monitoring
in Adults and Children with Diabetes

Lost Productivity and Impact on Daily Activities of Living with Diabetes

Lost Productivity and Impact on Daily Activities of Living with Diabetes dQ&A® Diabetes Research – 2019